Resources from the same session
What are the biological reasons for treatment resistance in pancreatic adenocarcinoma?
Presenter: David Chang
Session: ESMO Colloquium supported by Celgene - Pancreatic cancer: Can better understanding of biology improve resectability and survival?
Resources:
Slides
Webcast
What have we achieved with recent medical approaches to improve survival
Presenter: Thierry Conroy
Session: ESMO Colloquium supported by Celgene - Pancreatic cancer: Can better understanding of biology improve resectability and survival?
Resources:
Slides
Webcast
What benefit can we expect from emerging targeted agents including ICI to improve survival?
Presenter: Margaret Tempero
Session: ESMO Colloquium supported by Celgene - Pancreatic cancer: Can better understanding of biology improve resectability and survival?
Resources:
Slides